PDCD1 and plasma cell myeloma: Antibody blockade of TIGIT and the PD-1/PD-L1 axis enhanced tumour cell clearance by CD8+ T cells [88,89] and significantly prolonged control of myeloma in a mouse model of autologous stem cell transplantation [90].